Inderalxl
About Inderalxl
Manufacturer of extended-release beta-blocker medication for hypertension. This medication is designed to lower blood pressure, specifically targeting the risk of morning cerebrovascular events. It is available by prescription only and comes in 80mg and 120mg doses. The medication is not indicated for hypertensive emergencies. Important safety information includes the need for gradual discontinuation to avoid potential adverse effects. The product requires a prescription and should be taken as directed by a physician. Potential side effects include tiredness, dizziness, and constipation, among others. Interactions with other medications, such as warfarin and other beta-blockers, should be discussed with a healthcare provider before starting treatment. Breastfeeding is contraindicated while using this medication.
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
ANI Pharmaceuticals
(Feb 24, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Inderalxl
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Inderalxl
Inderalxl has secured backing from 1 investor. Prominent investors backing the company include ANI Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Inderalxl
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Inderalxl
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Inderalxl Comparisons
Competitors of Inderalxl
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Inderalxl
What does Inderalxl do?
Manufacturer of extended-release beta-blocker medication for hypertension. This medication is designed to lower blood pressure, specifically targeting the risk of morning cerebrovascular events. It is available by prescription only and comes in 80mg and 120mg doses. The medication is not indicated for hypertensive emergencies. Important safety information includes the need for gradual discontinuation to avoid potential adverse effects. The product requires a prescription and should be taken as directed by a physician. Potential side effects include tiredness, dizziness, and constipation, among others. Interactions with other medications, such as warfarin and other beta-blockers, should be discussed with a healthcare provider before starting treatment. Breastfeeding is contraindicated while using this medication.
Who are Inderalxl's investors?
Inderalxl has 1 investor. Key investors include ANI Pharmaceuticals.